Diphenoxylate Hydrochloride And Atropine Sulfate Tablet
Product Images NDC 70518-3915

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diphenoxylate Hydrochloride And Atropine Sulfate (NDC 70518-3915). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Packaging label for Diphenoxylate Hydrochloride and Atropine Sulfate tablets, strength 2.5 mg / 0.025 mg, oral dosage form. The label indicates a quantity of 30 tablets with a schedule C-V classification. It includes the NDC number 70518-3915-00, instructions to keep out of reach of children, and repackaging information by RemedyRepack Inc., Indiana, PA.*

FDA Label Image

Chemicalstructureatropine (Chemstructure 01)

Chemical structure diagram showing the molecular structure of atropine sulfate monohydrate, part of the combination drug Diphenoxylate Hydrochloride and Atropine Sulfate.*

FDA Label Image

Chemicalstructurediphen (Chemstructure)

Chemical structure of diphenoxylate hydrochloride, showing its molecular arrangement including aromatic rings, ester groups, and a nitrile moiety with an attached hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.